Pseudohypoaldosteronism, Type I
Oncology·MeSH: Pseudohypoaldosteronism
Prevalence
5.0 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Pseudohypoaldosteronism, Type I?
There are 1 clinical trial targeting Pseudohypoaldosteronism, Type I tracked by BioSniper.
What is the prevalence of Pseudohypoaldosteronism, Type I?
The estimated prevalence of Pseudohypoaldosteronism, Type I is approximately 5.0 per 100,000 population.
Deep-dive into Pseudohypoaldosteronism, Type I
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis